middle.news
Biotron’s new CEO starts early with SedRx in his sights
9:33am on Monday 9th of November, 2026 AEDT
•
Biotechnology
Read Story
Biotron’s new CEO starts early with SedRx in his sights
9:33am on Monday 9th of November, 2026 AEDT
Key Points
Glenn Gilbert commences immediately as CEO and executive director
Start date brought forward from 18 January 2027
SedRx regulatory, clinical, manufacturing and partnering pathways under review
BIT-HBV001 and additional neurology opportunities included in portfolio assessment
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Biotron (ASX:BIT)
OPEN ARTICLE